site stats

Onph stock analysis and price target

WebWebull offers kinds of Oncology Pharma Inc stock information, including OTCPK:ONPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONPH stock news, and many more online research tools to help you make informed decisions.

Oncology Pharma Inc. (ONPH) Stock Research & Reports

WebOncology Pharma slips on year-end operational update. Oncology Pharma (OTCPK:ONPH -7.1%) is on the decline following a year-end update on its portfolio and operations. The … WebAnalysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the … bing music quiz 1970 https://lyonmeade.com

Oncology Pharma Stock Forecast: down to 0.000001 USD? - ONPH …

WebFind the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing. WebOTC:ONPH Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Quickly zoom in on the stocks with highest and lowest potential based on analyst recommendations and Stock Target Advisor's own analysis Automatic Selection; Top Stocks; Worst ... WebOncology Pharma Inc. (ONPH) Other OTC - Other OTC Delayed Price. Currency in USD Follow 0.1728 +0.0001 (+0.03%) At close: 03:50PM EDT 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are... d2 how much cold mastery

Home Oncology Pharma Inc

Category:Oncology Pharma (ONPH) Stock Analysis: Price, Forecast, …

Tags:Onph stock analysis and price target

Onph stock analysis and price target

Oncology Pharma Inc. (ONPH) stock price, news, quote & history ...

WebTechnical analysis, on the other hand, focuses on the price and volume data of Oncology Pharma's stock to identify patterns and trends that may indicate its future price … WebGet the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Onph stock analysis and price target

Did you know?

Web11 de abr. de 2024 · Oncology Pharma - ONPH Competitors $0.33 +0.01 (+3.13%) (As of 03/14/2024 12:00 AM ET) Compare Today's Range $0.30 $0.34 50-Day Range $0.32 $0.44 52-Week Range $0.30 $4.37 Volume 11,056 shs Average Volume 49,054 shs Market Capitalization $12.76 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … WebOncology Pharma entered into a Licensing Agreement with NanoSmart®Pharmaceuticals Inc. for its "novel" drug delivery platform that can target many types of cancer and other diseases. One of the keys to NanoSmart's® platform technology is a “patented”(US 7,799,327 and EU 1706145 B1) human-derived, antinuclear antibody (ANA) that targets …

WebOncology Pharma Inc. (ONPH) Latest Stock News & Headlines - Yahoo Finance Industries U.S. markets close in 56 minutes S&P 500 4,103.50 -1.52(-0.04%) Dow 30 … Web24 de mar. de 2024 · What is the target price for Oncology Pharma (ONPH) stock? A There is no analysis for Oncology Pharma Q Current Stock Price for Oncology Pharma (ONPH)? A The stock price for...

Web25 de ago. de 2024 · View the latest ONPH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ONCOLOGY PHARMA, INC.. msn back … WebOncology Pharma (ONPH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. …

Web17 de jul. de 2024 · Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, … Is Oncology Pharma (OTCMKTS:ONPH) the best stock in the Prepackaged … Price Target N/A. Profile. Chart. Competitors. Headlines. ... Financial … Are hedge funds shorting Oncology Pharma (OTCMKTS:ONPH) stock? View the … Get The Latest HCMC Stock Forecast, Price Target, and Headlines at … 2 brokerages have issued 12-month price objectives for CareCloud's stock. Their … Get The Latest DCTH Stock Forecast, Price Target, Earnings Estimates, Headlines, … Get The Latest LFLY Stock Forecast, Price Target, Earnings Estimates, Headlines, … Get The Latest COCP Stock Forecast, Price Target, Earnings Estimates, Headlines, …

WebTL;DR. Price targets indicate the future estimated value of a stock. Analysts use popular valuation techniques such as the price-to-earnings (PE) ratio and discounted cash flow (DCF) analysis to determine a stock’s target price. There is no guarantee that a stock will reach or fall to an estimated target price. d2 how much cold mastery do i needWebOncology Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ONPH updated stock price target summary. Dow Jones, a News Corp company … bing music streamingWebONCOLOGY PHARMA, INC. +5.51% 0.7175 at close +0.04 (‎ +5.51%) Summary Earnings Investors Financials Analysis Options . . . Something went wrong. d2 how to bubble skateWebOur comprehensive analysis of fundamental and technical factors gives ONPH a rank of 3. Our methodology considers analysis of the company's financial situation and how it has … d2 how much mfWeb0NPH Stock 12 Months Forecast €18.90 (3.21% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Carrefour in the last 3 months. The average price target is €18.90 with a high forecast of €22.00 and a low forecast of €16.00. The average price target represents a 3.21% change from the last price of €18.31. d2 how magic find worksWebFind the latest ONCOLOGY PHARMA INC ONPH analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. bing music the whispersWebONPH Stock USD 0.39 0.01 2.50% Oncology Pharma stock price prediction is an act of determining the future value of Oncology Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. d2h owner